TrialBreast cancer research and treatment2022

IMPARTER, Phase 1 of an intervention to improve patients' understanding of gene expression profiling tests in breast cancer.

L J Fallowfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.